Analgesiometer Market Size, Share 2026

MARKET INSIGHTS

The global analgesiometer market size was valued at USD 187.5 million in 2025. The market is projected to grow from USD 197.4 million in 2026 to USD 278.9 million by 2034, exhibiting a CAGR of 4.4% during the forecast period.

Analgesiometers are specialized instruments used in pre-clinical research to quantitatively measure the pain threshold and analgesic efficacy in laboratory animals. These devices are crucial for evaluating the effectiveness of new pharmaceutical compounds, employing various methods such as mechanical pressure, thermal stimuli, or electrical impulses. Common types include Von Frey filaments for measuring mechanical allodynia, tail-flick and hot plate analgesiometers for thermal pain response, and weight-bearing platforms for assessing incapacitance.

The market growth is primarily driven by the increasing global focus on pain management research and the rising prevalence of chronic pain conditions, which necessitates extensive drug development. However, the market faces challenges, such as the growing ethical concerns and stringent regulations surrounding animal testing, which are pushing research towards alternative in-vitro methods. Furthermore, the consistent demand from academic institutions and pharmaceutical companies for reliable, high-throughput screening tools continues to support market expansion, particularly for advanced, automated systems that enhance data accuracy and reproducibility.

MARKET DYNAMICS

MARKET DRIVERS

Rising Global Burden of Chronic Pain and Neurological Disorders to Propel Market Demand

The escalating global prevalence of chronic pain conditions and neurological disorders is a primary catalyst for the analgesiometer market. Chronic pain, a leading cause of disability worldwide, affects an estimated 20% of the global adult population, with conditions like neuropathic pain, arthritis, and lower back pain driving significant demand for effective pain assessment tools in both clinical and research settings. Concurrently, the rising incidence of neurological disorders such as diabetic neuropathy, multiple sclerosis, and chemotherapy-induced peripheral neuropathy necessitates precise, quantitative pain measurement for diagnosis and therapeutic evaluation. This creates a sustained need for analgesiometers in pharmaceutical R&D for novel analgesic drug development and in academic neuroscience research. The growing emphasis on objective, reproducible pain quantification over subjective patient reports is further compelling healthcare providers and researchers to adopt these specialized instruments, thereby accelerating market expansion.

Accelerated Drug Discovery and Preclinical Research to Fuel Instrument Adoption

The robust growth in the global pharmaceutical and biotechnology sectors, particularly in pain management and neuroscience therapeutic areas, is a significant driver. The preclinical evaluation of new chemical entities (NCEs) for analgesic efficacy is a mandatory, resource-intensive phase. Analgesiometers, especially automated and high-throughput models like electronic Von Frey and dynamic plantar aesthesiometers, are indispensable for generating reliable, standardized data on pain thresholds and analgesic response. With the global pharmaceutical R&D expenditure consistently exceeding $240 billion annually and a substantial portion allocated to CNS and pain therapeutics, investment in advanced laboratory instrumentation is rising. Furthermore, stringent regulatory requirements for drug approval demand highly accurate and validated pain assessment data, making sophisticated analgesiometers a critical component of the research infrastructure. This trend is particularly pronounced in emerging biotech hubs across Asia-Pacific, where increasing local drug discovery initiatives are boosting regional demand.

Technological Advancements and Product Innovation to Enhance Market Growth

Continuous technological innovation is transforming the analgesiometer landscape, driving replacement cycles and adoption in new application areas. Traditional mechanical devices are being rapidly supplanted by digital, computerized, and software-integrated systems that offer superior accuracy, data logging capabilities, and reduced operator-induced variability. Recent developments include the integration of wireless connectivity for remote monitoring, touch-screen interfaces for simplified operation, and advanced software for real-time data analysis and compliance with Good Laboratory Practice (GLP) standards. For instance, leading manufacturers are launching products with features like automatic stimulus application, precise force measurement in grams, and integrated video recording for behavioral correlation. These innovations not only improve research outcomes but also expand the utility of analgesiometers from basic academic labs to high-throughput contract research organizations (CROs) and large pharmaceutical companies, thereby broadening the total addressable market.

➤ For instance, companies like IITC Life Science and Ugo Basile have recently introduced fully automated thermal and mechanical nociception testing systems that significantly reduce testing time and improve inter-experiment consistency, addressing key pain points in preclinical research workflows.

Furthermore, the increasing integration of analgesiometry data with other behavioral and physiological parameters in multi-modal research platforms is creating a more holistic approach to pain research, which in turn stimulates demand for compatible and advanced instrument systems.

MARKET CHALLENGES

High Instrument Costs and Budgetary Constraints in Academic and Emerging Markets

Despite growing demand, the market faces a significant challenge from the high capital cost of advanced analgesiometer systems. State-of-the-art electronic Von Frey or dynamic plantar instruments can cost several thousand dollars per unit, a substantial investment for academic research laboratories, small biotech firms, and institutions in developing regions that often operate under tight and fluctuating funding budgets. While basic mechanical models are more affordable, they lack the precision and data integrity required for many modern research protocols and regulatory submissions. This cost barrier can lead to extended use of outdated equipment, delay replacement cycles, or force researchers to rely on less optimal assessment methods. In price-sensitive markets, particularly in parts of Asia, Africa, and Latin America, this financial hurdle significantly dampens market penetration and growth rates, as funding for laboratory capital equipment often competes with other pressing priorities like personnel and consumables.

Other Challenges

Technical Complexity and Standardization Issues

The effective operation and interpretation of data from advanced analgesiometers require specialized technical expertise. Variability in testing protocols, animal models, and data analysis methods across different laboratories can lead to challenges in reproducing and comparing results, a critical issue in multi-center preclinical studies. The lack of universally standardized testing paradigms, despite guidelines from bodies like the International Association for the Study of Pain (IASP), can create uncertainty and affect the perceived reliability of the instruments themselves, potentially slowing adoption.

Ethical and Regulatory Scrutiny on Animal Testing

The analgesiometer market, heavily reliant on preclinical animal research, is subject to the intensifying global ethical debate and regulatory scrutiny surrounding animal testing. Stricter regulations, such as the EU's Directive 2010/63/EU, mandate the principles of Replacement, Reduction, and Refinement (the 3Rs). This pressures researchers to justify animal use and seek alternative methods where possible. While this drives demand for more refined and humane instruments, it also creates a long-term challenge as the industry explores non-animal models, which could eventually reduce the volume of traditional analgesiometer-based studies.

MARKET RESTRAINTS

Limited Awareness and Access in Underserved Regions to Constrain Geographic Expansion

A key restraint on the global analgesiometer market is the uneven distribution of awareness and access to advanced research instrumentation. While North America and Europe represent mature markets with high penetration in research institutions and pharmaceutical companies, many regions in the developing world have limited exposure to the latest pain assessment technologies. Research infrastructure in these areas may prioritize basic clinical diagnostics over specialized preclinical research tools. This knowledge and access gap is compounded by a shortage of local distributors and technical support networks for specialized manufacturers, making procurement, maintenance, and training difficult. Consequently, a substantial portion of the global research potential remains untapped, restraining the overall market growth. Bridging this gap requires concerted efforts in education, partnerships with local academic bodies, and the development of more cost-effective product variants tailored for these markets.

Competition from Alternative and Emerging Pain Assessment Methodologies

The market growth for traditional analgesiometers is partially restrained by the development and gradual adoption of alternative pain assessment technologies. While analgesiometers measure evoked pain responses (like withdrawal reflexes), there is growing research interest in measuring spontaneous pain behaviors, conditioned place preference/aversion, and facial grimacing scales in animals, which may require different observational tools. More significantly, the advent of in vitro models, organ-on-a-chip technologies, and advanced neuroimaging techniques promises to provide insights into pain mechanisms without behavioral animal testing. Although these alternatives are not yet positioned to replace in vivo analgesiometry for final efficacy testing, they are capturing a share of early-stage discovery research funding. This competitive pressure encourages innovation within the analgesiometer segment but also poses a long-term restraint on volume growth if the shift towards complementary and alternative methods accelerates.

MARKET OPPORTUNITIES

Expansion into New Therapeutic Areas and Contract Research to Unlock New Revenue Streams

The application scope of analgesiometers is expanding beyond traditional pain and neuropathy research, presenting lucrative growth opportunities. There is increasing utilization in studying pain comorbidities in conditions like autoimmune diseases, metabolic disorders (e.g., diabetes), and oncology, where pain is a significant symptom. Furthermore, the burgeoning field of migraine and headache research is adopting specialized models that use analgesiometers. Simultaneously, the explosive growth of the global Contract Research Organization (CRO) market, valued at over $73 billion and growing steadily, represents a major opportunity. CROs conducting preclinical services for pharmaceutical clients require standardized, high-quality, and auditable data, making them prime customers for advanced, GLP-compliant analgesiometer systems. Establishing dedicated product lines and service agreements with large CRO networks can provide manufacturers with stable, high-volume demand channels.

Strategic Focus on Emerging Economies and Localized Product Development

Emerging economies, particularly China and India, present a high-growth opportunity driven by massive government and private investments in biomedical research and pharmaceutical innovation. China's "Made in China 2025" initiative and India's growing biotech sector are fostering world-class research infrastructure. This is coupled with increasing local production of research equipment to reduce import dependency. For global analgesiometer manufacturers, this creates an opportunity for strategic partnerships, joint ventures, or the establishment of local manufacturing units to offer competitively priced products. Developing simplified, robust, and cost-effective models specifically for these markets, while providing strong local technical support and training, can enable significant market share capture in these rapidly expanding regions, offsetting slower growth in mature markets.

Integration with Digital Platforms and Data Analytics Services to Create Value-Added Solutions

The convergence of laboratory instrumentation with digital technology opens a frontier for value creation. There is a significant opportunity for manufacturers to evolve from selling standalone hardware to providing integrated pain research platforms. This involves bundling analgesiometers with proprietary software for cloud-based data management, advanced statistical analysis, and compliance reporting. Offering subscription-based data analytics services or integrating instruments with laboratory information management systems (LIMS) can create recurring revenue models and deepen customer relationships. Furthermore, the development of multi-modal stations that combine pain threshold testing with other behavioral or physiological monitoring (e.g., locomotor activity, cardiovascular parameters) in a single, synchronized system addresses the growing demand for comprehensive phenotyping in preclinical research, allowing companies to command premium pricing and secure long-term customer loyalty.

Segment Analysis:

By Type

Von Frey Type Segment Dominates the Market Due to its Widespread Use in Mechanosensitivity Pain Research

The market is segmented based on type into:

• Von Frey Type

  • Subtypes: Manual filament sets, Electronic von Frey anesthesiometers, and others

• Tail-Flick Type

• Weight Bearing

• Others

  • Subtypes: Hot plate analgesiometers, Paw pressure tests, and others

By Application

Scientific Research Segment Leads Due to Extensive Use in Preclinical Pharmacology and Neurobiology

The market is segmented based on application into:

• Scientific Research

  • Subtypes: Academic research, Pharmaceutical R&D, and others

• Grip Test

• Veterinary Research

• Others

  • Subtypes: Clinical diagnostics and specialized industrial testing

By End User

Academic & Research Institutes Hold the Largest Share Due to High Volume of Basic Pain Research

The market is segmented based on end user into:

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Contract Research Organizations (CROs)

• Veterinary Clinics & Research Centers

By Technology

Electronic/ Automated Systems are Gaining Traction for Enhanced Accuracy and Data Integrity

The market is segmented based on technology into:

• Manual Systems

• Electronic/ Automated Systems

  • Subtypes: Computer-integrated von Frey, Automated tail-flick, and others

• Hybrid Systems

COMPETITIVE LANDSCAPE

Key Industry Players

Innovation and Specialization Drive Competition in a Fragmented Arena

The competitive landscape of the global analgesiometer market is highly fragmented, characterized by a mix of specialized niche manufacturers and a few established players with broader life science portfolios. Unlike high-volume medical device sectors, this market is driven by precision, reliability, and application-specific features tailored for preclinical pain research. The market's fragmentation is a direct result of the specialized nature of the equipment, which is primarily used in academic research institutions, pharmaceutical R&D, and contract research organizations (CROs).

While no single company commands a dominant global share, certain players have established strong reputations through technological leadership and deep market penetration. Columbus Instruments and IITC Life Science are often cited as key innovators, particularly for electronic von Frey and tail-flick type analgesiometers. Their growth is attributed to continuous product refinement, strong relationships with the scientific community, and a focus on integrating digital data acquisition systems that enhance reproducibility and compliance with data integrity standards in research.

Meanwhile, companies like Ugo Basile and Panlab (a part of Harvard Apparatus) have strengthened their market presence through comprehensive behavioral research portfolios. Their strategy involves offering integrated systems for pain, motor function, and cognitive testing, which provides a significant value proposition for labs seeking standardized platforms. These players invest significantly in R&D for multi-modal testing apparatus and strategic partnerships with software developers to create seamless workflow solutions.

Additionally, the competitive dynamics are influenced by regional specialists and cost-competitive manufacturers. For instance, companies such as Meditech Technologies India and Orchid Scientific are strengthening their positions, particularly in the Asia-Pacific region, by offering robust products at competitive price points. This is crucial for expanding research capabilities in emerging biotech hubs. Their growth initiatives often focus on direct sales channels and collaborations with local academic consortia.

The market is also witnessing a trend where traditional players face competition from newer entrants like Labkafe and MazeEngineers, which leverage e-commerce and digital marketing to reach a global base of individual researchers and smaller labs. The overall competitive intensity is expected to increase further as companies strive to launch more automated, user-friendly, and data-rich systems to capture growth in the expanding neuroscience and analgesic drug development sectors.

List of Key Analgesiometer Companies Profiled

• Columbus Instruments (U.S.)

• IITC Life Science (U.S.)

• Ugo Basile S.R.L. (Italy)

• Panlab (Harvard Apparatus) (Spain/U.S.)

• Bioseb (France/U.S.)

• San Diego Instruments (U.S.)

• Muromachi Kikai Co., Ltd. (Japan)

• Meditech Technologies India Pvt. Ltd. (India)

• Orchid Scientific & Innovative India Pvt Ltd (India)

• Labkafe (India)

• MazeEngineers (U.S.)

• Bonther (China)

ANALGESIOMETER MARKET TRENDS

Integration of Digital and Automated Systems to Emerge as a Leading Trend

A significant trend reshaping the analgesiometer market is the accelerating integration of digital interfaces and automated systems into traditional mechanical devices. This evolution is driven by the growing demand for high-throughput, reproducible, and data-rich pain assessment in both pharmaceutical research and academic studies. Modern analgesiometers are increasingly equipped with digital force gauges, integrated software for data acquisition, and automated stimulus application, which minimize user-induced variability and enhance experimental precision. For instance, automated Von Frey systems can conduct sequential filament applications and log withdrawal thresholds directly into a connected database, streamlining workflows in chronic pain studies. This digital transformation is a direct response to the stringent data integrity requirements of regulatory bodies and the need for efficient preclinical testing in the face of rising R&D expenditures for novel analgesics, which are estimated to exceed $80 billion globally. The shift is not merely about replacing analog dials with digital screens; it represents a fundamental move towards connected laboratory ecosystems where pain behavior data can be seamlessly integrated with other physiological parameters for more comprehensive neurobiological analysis.

Other Trends

Expansion in Neuropathic and Chronic Pain Research

The sustained global focus on understanding and treating neuropathic and chronic pain conditions is a powerful driver for the analgesiometer market. With an estimated 20% of the global population affected by chronic pain, and the neuropathic pain segment of the pharmaceutical market projected for substantial growth, the demand for reliable preclinical pain models is intensifying. This has led to increased utilization of specialized analgesiometers, particularly electronic Von Frey and dynamic plantar aesthesiometer systems, which are adept at measuring the mechanical allodynia and hyperalgesia characteristic of these conditions. Research into conditions like chemotherapy-induced peripheral neuropathy, diabetic neuropathy, and post-surgical pain models relies heavily on these precise quantification tools. Consequently, manufacturers are developing application-specific protocols and accessories, such as chambers for unrestrained testing or systems calibrated for specific rodent models of disease, to cater to this deepening specialization within pain research.

Growing Emphasis on Refinement in Animal Welfare Standards

The market is also being shaped by the global push for the refinement of animal testing protocols in accordance with the "3Rs" principle (Replacement, Reduction, Refinement). Regulatory agencies and institutional animal care committees are mandating more humane endpoints and less stressful testing methodologies. This ethical imperative is catalyzing innovation in analgesiometer design. Newer devices prioritize minimizing restraint stress and enabling behavioral testing in more naturalistic or home-cage environments. For example, touchscreen-based operant systems for pain assessment and weight-bearing systems that allow for voluntary limb use measurement are gaining traction as they reduce animal distress and generate more clinically relevant data. This trend is not just ethical but also practical, as data obtained from less-stressed animals is considered more reliable, thereby improving the translational value of preclinical studies. The adoption of such refined equipment is becoming a benchmark for high-quality research, influencing purchasing decisions in academic, government, and industrial laboratories worldwide.

Regional Analysis: Analgesiometer Market

North America

North America, led by the United States, represents a mature and technologically advanced market for analgesiometers. The region's dominance is anchored in its robust biomedical research ecosystem, substantial R&D funding from both public institutions like the National Institutes of Health (NIH) and private pharmaceutical giants, and a high concentration of academic and contract research organizations (CROs). The U.S. market size, estimated at a significant value in 2025, is driven by the continuous demand for preclinical pain research, particularly in developing novel therapeutics for chronic pain conditions, which affect over 20% of the U.S. adult population. Regulatory standards from bodies like the FDA mandate rigorous preclinical testing, directly fueling the adoption of precise and reliable equipment such as Von Frey and Tail-Flick type analgesiometers. Key players like Columbus Instruments, IITC Life Science, and San Diego Instruments have a strong presence here, focusing on innovation through digital integration and automated testing protocols. However, the market faces challenges from high product costs and the need for specialized training, which can limit adoption in smaller laboratories. The trend is firmly towards sophisticated, data-integrated systems that enhance reproducibility and comply with Good Laboratory Practice (GLP) standards.

Europe

Europe stands as another critical market, characterized by stringent regulatory frameworks for animal research and ethical compliance, which shape the demand for high-precision and humane testing equipment. The European Union's Directive 2010/63/EU on the protection of animals used for scientific purposes enforces the principles of Replacement, Reduction, and Refinement (the 3Rs), pushing manufacturers to develop analgesiometers that minimize animal stress and improve data accuracy. This regulatory environment, coupled with strong public and private investment in life sciences exemplified by programs like Horizon Europe supports steady market growth. Countries such as Germany, the United Kingdom, and France are major contributors, hosting world-renowned research institutes and pharmaceutical companies. The presence of established companies like Panlab (a Harvard Apparatus company) and Ugo Basile underscores the region's focus on quality and innovation. The market is seeing a shift towards multi-modal testing systems that combine various pain assessment methods (e.g., mechanical, thermal) into single platforms, catering to comprehensive research needs. While price sensitivity exists among academic buyers, the overarching driver is the uncompromising demand for validated, reliable instrumentation that meets rigorous ethical and scientific standards.

Asia-Pacific

The Asia-Pacific region is the fastest-growing market for analgesiometers, propelled by explosive expansion in biomedical research, pharmaceutical outsourcing, and government initiatives to bolster life sciences infrastructure. China, aiming to reach a substantial market value by 2025, and India are the primary engines of this growth. This is driven by massive investments in biotechnology parks, a growing number of CROs catering to global drug development pipelines, and increasing R&D expenditures by domestic pharmaceutical companies. The region benefits from cost-effective manufacturing, with several key suppliers like Labkafe, Meditech Technologies India, and Orchid Scientific operating locally, offering competitive pricing that appeals to a broad customer base from academic labs to emerging biotech firms. The product mix is diverse, with strong demand for both basic Von Frey filaments and more advanced electronic analgesiometers. However, the market is fragmented, and quality standards can vary significantly. A key trend is the gradual but steady transition from manual, low-cost devices to automated digital systems, as research quality and data publication requirements intensify. While intellectual property concerns and a preference for lower-cost models present challenges, the long-term trajectory is overwhelmingly positive due to the region's strategic focus on becoming a global hub for drug discovery and preclinical research.

South America

The South American market for analgesiometers is in a developing phase, with growth primarily concentrated in Brazil and Argentina. Market expansion is tied to the gradual strengthening of national scientific research capabilities and increasing participation in international collaborative studies. Public funding agencies in Brazil, such as CNPq and CAPES, support neuroscience and pharmacology research, creating a foundational demand for essential laboratory equipment like analgesiometers. The market is characterized by a high degree of price sensitivity and a reliance on imports from North American, European, and increasingly, Asian manufacturers. Local manufacturing is limited, which can lead to longer lead times and higher final costs due to tariffs and logistics. Economic volatility and currency fluctuations in the region pose significant challenges for both suppliers and buyers, often constraining capital expenditure for advanced research tools. Consequently, demand leans heavily towards durable, cost-effective, and versatile models, often favoring mechanical Von Frey sets over sophisticated electronic units. Nonetheless, as universities and research centers strive to enhance their publication output and global research standing, there is a slow but perceptible increase in demand for more precise and automated instruments, indicating a market with latent potential awaiting greater economic stability and sustained research investment.

Middle East & Africa

The analgesiometer market in the Middle East and Africa is nascent and emerging, with activity focused on specific, well-funded nodes. In the Middle East, nations like Saudi Arabia, Israel, and the United Arab Emirates are driving demand through ambitious national visions (e.g., Saudi Vision 2030) that prioritize biotechnology and healthcare research. Israel, with its strong innovation ecosystem, shows particular promise for adopting advanced research tools. These countries are investing in new research universities and medical centers, creating pockets of demand for high-quality preclinical research equipment. In contrast, the broader African market remains constrained by severe limitations in research funding, infrastructure, and technical expertise. South Africa represents the most established market on the continent. Across the region, the market is almost entirely served by imports, with distributors playing a crucial role. The primary challenges are multifaceted: limited awareness of specialized equipment, budget constraints that prioritize basic laboratory needs over niche instruments like analgesiometers, and a scarcity of trained personnel. Therefore, market growth is incremental and closely tied to large-scale government or international grants aimed at building research capacity. Suppliers often find success with robust, user-friendly, and service-supported entry-level models, as the market's long-term development hinges on the sustained institutional building of life sciences research.

Report Scope

This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2034. It presents accurate and actionable insights based on a blend of primary and secondary research.

Key Coverage Areas:

• ✅ Market Overview

  • Global and regional market size (historical & forecast)

  • Growth trends and value/volume projections

• ✅ Segmentation Analysis

  • By product type or category

  • By application or usage area

  • By end-user industry

  • By distribution channel (if applicable)

• ✅ Regional Insights

  • North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

  • Country-level data for key markets

• ✅ Competitive Landscape

  • Company profiles and market share analysis

  • Key strategies: M&A, partnerships, expansions

  • Product portfolio and pricing strategies

• ✅ Technology & Innovation

  • Emerging technologies and R&D trends

  • Automation, digitalization, sustainability initiatives

  • Impact of AI, IoT, or other disruptors (where applicable)

• ✅ Market Dynamics

  • Key drivers supporting market growth

  • Restraints and potential risk factors

  • Supply chain trends and challenges

• ✅ Opportunities & Recommendations

  • High-growth segments

  • Investment hotspots

  • Strategic suggestions for stakeholders

• ✅ Stakeholder Insights

  • Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers

FREQUENTLY ASKED QUESTIONS:

What is the current market size of the Global Analgesiometer Market?

-> The global analgesiometer market was valued at USD 12.8 million in 2025 and is projected to reach USD 18.5 million by 2034, growing at a CAGR of 4.2% during the forecast period.

Which key companies operate in the Global Analgesiometer Market?

-> Key players include Labkafe, MazeEngineers, Bonther, Columbus Instruments, Panlab, IITC Life Science, Bioseb, Meditech Technologies India, Muromachi Kikai, Orchid Scientific and Innovative India Pvt Ltd, Harvard Apparatus, San Diego Instruments, and Ugo Basile. The global top five players held an approximate 45% revenue share in 2025.

What are the key growth drivers?

-> Key growth drivers include the rising prevalence of chronic pain conditions, increasing investment in neuroscience and pharmaceutical R&D, and stringent regulatory requirements for preclinical animal testing of new analgesics and therapeutics.

Which region dominates the market?

-> North America is the dominant market, with the U.S. market size estimated at USD 4.7 million in 2025. Asia-Pacific is the fastest-growing region, with China's market projected to reach USD 3.2 million by 2034.

What are the emerging trends?

-> Emerging trends include the integration of digital sensors and software for automated data capture, development of multi-modal testing systems, and increasing demand for high-throughput, validated pain assessment tools to accelerate drug discovery pipelines.